No Data
Neptune Interlon (08329) announced its first quarter results. Profit attributable to shareholders of 19.3 million yuan increased 18.67% year over year
Neptune Interlon (08329) announced the first quarter results for the three months ended March 31, 2024. The group took...
NEP INTERLONG: ABSTRACT OF THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024
Neptune Interlon (08329.HK) will purchase medical devices from the Neptune Group
Gelonghui, May 7, 丨 Neptune Interlon (08329.HK) announced that the company and Neptune Biotech (the company's controlling shareholder and related party) entered into a 2024 framework agreement on May 7, 2024. Based on this, the Group will purchase medical devices from Haiwang Group to be sold on behalf of China.
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings
NEP INTERLONG: 2023 Annual Report
Neptune Interlon Announces 2023 Results Profit attributable to shareholders of 24.127 million, a year-on-year decrease of 55.6%
Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, up about 7.92% year on year; profit attributable to company owners was 24.127 million yuan, a decrease of 55.6% year on year; profit per share was 1.44 points.
No Data
